Yes, Aristada Treats Schizophrenia
Aristada (aripiprazole lauroxil) is an injectable antipsychotic medication approved by the FDA for treating schizophrenia in adults. Schizophrenia is a serious mental health disorder involving symptoms like hallucinations, delusions, disorganized thinking, and reduced motivation.[1]
How Aristada Works in Mental Health Treatment
It acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, helping stabilize brain chemical imbalances linked to psychotic symptoms. Administered as a long-acting intramuscular injection every 4 to 8 weeks, it improves treatment adherence compared to daily oral antipsychotics.[1][2]
Common Uses and Who It's For
Prescribed specifically for maintenance treatment of schizophrenia after initial stabilization with oral antipsychotics. Not approved for bipolar disorder, depression, or other conditions, though off-label use is rare and not recommended.[1]
Dosage Options and Administration
Available in 441 mg, 662 mg, 882 mg, and 1064 mg doses. A single 661 mg dose provides one day of oral antipsychotic coverage during initiation. Given by healthcare professionals in a clinic or hospital setting.[2]
Side Effects Patients Report
Frequent issues include akathisia (restlessness), weight gain, headache, injection-site pain, and sedation. Serious risks: tardive dyskinesia (involuntary movements), neuroleptic malignant syndrome, high blood sugar, and increased mortality in elderly dementia patients (black box warning).[1][2] Patients often ask about metabolic changes and long-term movement disorders.
How It Compares to Other Antipsychotics
| Medication | Type | Dosing Frequency | Key Difference |
|------------|------|------------------|---------------|
| Aristada | Long-acting injectable | Every 4-8 weeks | Higher adherence; prodrug converts slowly to aripiprazole |
| Abilify Maintena (aripiprazole) | Long-acting injectable | Every 4 weeks | Same active drug but different formulation; Aristada allows flexible dosing |
| Invega Sustenna (paliperidone) | Long-acting injectable | Every 4 weeks | Targets different receptor profile; more prolactin elevation |
| Oral risperidone | Daily pill | Daily | Lower adherence; shorter action |
Aristada edges out orals for relapse prevention but may cause more injection-related discomfort.[3]
Alternatives If Aristada Isn't Suitable
Switch to other long-acting injectables like Abilify Maintena, Invega Trinza (every 3 months), or oral options like olanzapine. Factors: side effect tolerance, cost, and insurance coverage.[3]
Cost and Access Concerns
Monthly cost averages $3,000-$4,000 without insurance; patient assistance programs from manufacturer Alkermes reduce it for eligible users. Biosimilars not yet available.[4]
[1]: FDA Label - Aristada (aripiprazole lauroxil). https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207533lbl.pdf
[2]: Aristada Prescribing Information. Alkermes. https://aristada.com/
[3]: Clinical Studies in Schizophrenia - PubMed Review. https://pubmed.ncbi.nlm.nih.gov/29504856/
[4]: DrugPatentWatch - Aristada Patents. https://www.drugpatentwatch.com/p/tradename/ARISTADA